title: Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study.
authors.forename: Santiago
authors.initials: S
authors.lastname: Moreno
authors.forename: Pere
authors.initials: P
authors.lastname: Domingo
authors.forename: Rosario
authors.initials: R
authors.lastname: Palacios
authors.forename: Jesús
authors.initials: J
authors.lastname: Santos
authors.forename: Vicenç
authors.initials: V
authors.lastname: Falcó
authors.forename: Javier
authors.initials: J
authors.lastname: Murillas
authors.forename: Vicente
authors.initials: V
authors.lastname: Estrada
authors.forename: Javier
authors.initials: J
authors.lastname: Ena
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Alvarez
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine